Partner Content
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them…
Harnessing the power of cell and gene therapy in oncology
By 2029, the global cell and gene therapy market is projected to be worth more than $81bn, according to GlobalData’s…
A proactive, data-driven approach to closing care gaps in heart disease
"Cardiovascular disease is preventable in many cases and early identification of risk is essential, especially for people at high risk," emphasizes…
Overcoming the added patient burden in DCTs
Decentralised clinical trials (DCTs) have long been heralded as the solution to many problems encountered in pharmaceutical research, most notably…
Oncology in 2024: The clinical trial trends reshaping the role of CROs
Oncology is the most active area in clinical trials globally this year, as more resources than ever are being dedicated…
Prevention over cure? Understanding the evolved care continuum and centralised data
You’ve heard the phrase “prevention is better than the cure”. It's generally attributed to the Dutch philosopher Desiderius Erasmus in…
Empowering clinical trials: The technological revolution in patient retention
Recent years have seen a promising trend: the application of technology to revolutionise patient engagement and retention strategies. From mobile…
PRPs: What is a Patient Recruitment Platform (and why do you need one)?
The rise of sophisticated software solutions in clinical trials is equipping sponsors and their CROs with the advanced tools necessary…
Quality versus quantity in T-cell production: Why it doesn’t have to be a trade-off
Unlocking the potential of T cells offers hope to a range of patients with serious diseases, such as cancer, and…
The key products you need to trust your host-cell protein analysis and other process related impurity results
Developing and commercialising gene therapies can be a costly process. Specialised manufacturing facilities are required, and custom medicines can only…